Quote | Progenity Inc. (NASDAQ:PROG)
Last: | $0.8845 |
---|---|
Change Percent: | -3.47% |
Open: | $0.9005 |
Close: | $0.8845 |
High: | $0.92 |
Low: | $0.84 |
Volume: | 2,720,100 |
Last Trade Date Time: | 05/06/2022 04:54:39 pm |
News | Progenity Inc. (NASDAQ:PROG)
SAN DIEGO, April 08, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc . (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today announced the issuance of a new patent related to the company’s BioJet™ platform for oral, systemic delivery of biotherapeu...
All pharmacokinetic endpoints were achieved, with a PK profile consistent with drug delivery and absorption in the colon All NaviCap™ devices performed as intended and were well tolerated, with no safety signals observed Multiple-ascending dose (MAD) portion of the trial ...
Message Board Posts | Progenity Inc. (NASDAQ:PROG)
Subject | By | Source | When |
---|---|---|---|
Is Biora Therapeutics (PROG) Stock About to Go Big? | AstronautApe_888 | investorshub | 01/12/2023 4:52:18 AM |
What happened here...it looks like trading has halted | pinkslipjunkie | investorshub | 06/17/2022 8:52:24 PM |
Hi, what to expect on the 28th ? | Hobbydigger-53 | investorshub | 03/26/2022 8:48:32 PM |
You got that right! | nathanial | investorshub | 03/19/2022 9:16:19 PM |
The pumpers got ahead of it last time | Deano361 | investorshub | 03/18/2022 3:14:10 PM |
News, Short Squeeze, Breakout and More Instantly...
Progenity Inc. Company Name:
PROG Stock Symbol:
NASDAQ Market:
SAN DIEGO, April 08, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc . (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today announced the issuance of a new patent related to the company’s BioJet™ platform for oral, systemic delivery of biotherapeu...
All pharmacokinetic endpoints were achieved, with a PK profile consistent with drug delivery and absorption in the colon All NaviCap™ devices performed as intended and were well tolerated, with no safety signals observed Multiple-ascending dose (MAD) portion of the trial ...
SAN DIEGO, April 03, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc . (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today announced the closing of its previously announced registered direct offering of an aggregate of 5,454,548 shares of the Company’s ...